CDC

CDC
Formation	July 1, 1946
Parent organization	United States Public Health Service
Subpage	•CDC/CDC Foundation corporate support list •CDC/Director •CDC/MMR vaccine fraud

Intellectual property claims

In 2010, the US Centers for Disease Control and Prevention was granted patent #CA2741523A1 on a particular strain of ebola - that is, it claims to have invented that disease strain. Natural News has questioned whether the desire to increase its patent portfolio and explain the decision to bring sufferers of the 2014 ebola outbreak to USA.

 

Related Quotations

Page	Quote	Author	Date
Francis Boyle	“I have absolute proof from a Pentagon document that the Centers for Disease Control and Prevention (CDC) was doing bio-warfare work for the Pentagon in Sierra Leone, the heart of the outbreak, as early as 1988. Why would they do that? As I suggested to try to circumvent the Biological Weapons Convention to which the US government is a party. So, always bio-warriors do use offensive and defensive bio-warfare work, violating the Biological Weapons Convention. So effectively they try to offshore it into West Africa where Liberia is not a party and Guinea is not a party. Sierra Leone is a party. But in Sierra Leone and Liberia there were disturbances which kept the world from really paying attention of what was going on in these labs.<a href="#cite_note-4">[4]</a>”	Francis Boyle
Warren Buffett	“In the pharmaceutical world of economic durable competitive advantages, having a patent on a best-selling drug is about as good as it gets. The next best thing is having a monopoly on selling a country’s national health program the vaccines it needs for its childhood inoculation programs. Both of these businesses are hugely profitable and GSK (GlaxoSmithKline) excels in both these categories. The vaccine business is particularly attractive because an individual shot (or jab) costs GSK approximately $1.50 to manufacture and it sells to national vaccine programs for approximately $9 a shot. That gives GSK a net profit of approximately $7.50 a shot. This markup gives GSK a very healthy profit margin that improves with each and every new disease that the company develops a vaccine for. Consider this: GSK's profits rose 10% with the 2009 Swine Flu outbreak—a disease for which the company had a state-of-the-art vaccine ready to inoculate the masses. In addition to its patents and the durable competitive advantage GSK has with the vaccines, it also established the relationships with the world's governments, and it has the financial capital to create, manufacture, and sell vaccines on a world scale. If you were in charge of the health of a nation's 30 million-plus children, who would you buy your vaccines from? Every year? Year after year? You’d pick the biggest and the best. There are only four pharmaceutical giants that control most of the vaccine production in the world and GSK is one of them. There is another component to the vaccine equation that also spells BIG MONEY: Every year, women all over the world give birth to approximately 133 million new babies, 4.3 million babies in the U.S. alone. With the United States Centers for Disease Control (CDC) recommending that children aged birth through six receive 34 individual vaccine shots/jabs, that means the market for those 34 vaccine shots/jabs increases every year by 4.3 million in just the U.S. alone. This in turn means that the vaccine manufacturers selling in the U.S. have the potential to earn a profit of $1.09 billion every year (4.3 million x 34 x $7.50 = $1.09 billion). Consider the number of yearly vaccines worldwide and the numbers are staggering—approximately $34 billion a year (133 million x 34 x $7.50 = $33.9 billion). After ten years, in the U.S. alone, vaccine manufacturers will see more than $10 billion in net profit. On a world scale, the number jumps to a potential $340 billion in profits. And wait, it gets even better. With the invention of each new vaccine comes a patent that is good for twenty years and guarantees that no one else can make the vaccine. In other words, the company has a monopoly. Even when the patents expire, other companies rarely step into the market because the major manufacturers have a permanent relationship with the government health departments of the world. This enables manufacturers to continue making the same vaccines year after year while maintaining their large profit margins even after their patents have expired. And last but not least, vaccine manufacturers in the US are completely immune from lawsuits. Back in the 1980s several bad batches of vaccines injured so many children that the resulting successful lawsuits threatened to bankrupt the manufacturers, so the manufacturers lobbied a bill through Congress making them a protected class.”	Warren Buffett Mary Buffett	2011

 

Event Planned

Event	Start	End	Description
Tuskegee syphilis experiment	1932	1972	A murderous experiment which looked at the progression of syphilis. Subjects were told that they were being treated, while in fact treatment was denied them. Exposed after 40 years by a whistleblower who went to the press.

 

Event Participated in

Event	Start	End	Location(s)
Simpsonwood Conference	7 June 2000	8 June 2000	Simpsonwood Georgia (State)

 

Related Document

Title	Type	Publication date	Author(s)	Description
Document:Why are government experts holding off vaccinating under-16s in the UK?	Article	6 August 2021	Deepti Gurdasani	Pro COVID-19/Vaccine propaganda from an epidemiologist with ties to Big Pharma. The JCVI does not recommend jabs for under-16s and the approval process has slowed down. The rushed vaccination process is not rushed enough apparently.

Many thanks to our Patrons who cover ~2/3 of our hosting bill. Please join them if you can.

References

This is a page stub. Please add to it.